| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 3, 244-253, Copyright © 1992 by American Society of Nephrology
REGULAR ARTICLES |
FA Carone, S Nakamura, P Punyarit, YS Kanwar and WJ Nelson
Department of Pathology, Northwestern University Medical School, Chicago, IL 60611-3008.
Tubular basement membrane (BM) changes (dysmorphogenesis), cell proliferation, and fluid accumulation related to the altered location of Na,K-ATPase are purported essential key events in the development and progression of renal cysts. These changes were assessed daily in Phenol II (2-amino-4-hydroxyphenyl-5-phenyl thiazole)-treated rats, which rapidly develop marked and progressive cystic change of all collecting tubules (CT). At Day 1, 12% of CT were cystic and their BM were thickened severalfold. At Day 4, 30% of CT were cystic and their BM remained thickened. BM of cystic tubules showed decreased staining for heparan sulfate proteoglycan and increased staining for fibronectin. Proliferation, as determined by (3H)thymidine, incorporation, was not significant until Day 2 and involved cystic and noncystic tubular cells as well as interstitial cells. As cystic changes progressed, cell proliferation decreased. By immunohistochemistry, the altered location of Na,K-ATPase in epithelial cells lining cysts was primarily detected after Day 2 and consisted of focal loss from basal and/or lateral cell membranes and localization in the cell cytoplasm. Only rarely was Na,K-ATPase localized to the apical cell membrane. After the removal of Phenol II, cystic tubular cells, BM, and Na,K-ATPase returned to normal. Thus, in this model of polycystic kidney disease, initial cyst formation occurred in tandem with BM structural change whereas cell proliferation and altered location of Na,K-ATPase occurred after the appearance of cysts.
This article has been cited by other articles:
![]() |
E. Condac, R. Silasi-Mansat, S. Kosanke, T. Schoeb, R. Towner, F. Lupu, R. D. Cummings, and M. E. Hinsdale Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis PNAS, May 29, 2007; 104(22): 9416 - 9421. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Scheffers, P. van der Bent, F. Prins, L. Spruit, M. H. Breuning, S. V. Litvinov, E. de Heer, and D. J.M. Peters Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells Hum. Mol. Genet., November 1, 2000; 9(18): 2743 - 2750. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Muller and A. Brandli Cell adhesion molecules and extracellular-matrix constituents in kidney development and disease J. Cell Sci., January 11, 1999; 112(22): 3855 - 3867. [Abstract] [PDF] |
||||
![]() |
L. P. SULLIVAN, D. P. WALLACE, and J. J. GRANTHAM Epithelial Transport in Polycystic Kidney Disease Physiol Rev, October 1, 1998; 78(4): 1165 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.W. Mays, W.J. Nelson, and J.A. Marrs Generation of Epithelial Cell Polarity: Roles for Protein Trafficking, Membrane-Cytoskeleton, and E-Cadherin-mediated Cell Adhesion Cold Spring Harb Symp Quant Biol, January 1, 1995; 60(0): 763 - 773. [Abstract] [PDF] |
||||
![]() |
P. A. Gabow Autosomal Dominant Polycystic Kidney Disease N. Engl. J. Med., July 29, 1993; 329(5): 332 - 342. [Full Text] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673